Controlling Mycoplasma hyopneumoniae infections in the field
No single strategy will confer total protection. A well-orchestrated combination of various methods adjusted to a single production unit or system will be needed.
Page 3 of articles about mycoplasma
New Swine Claim for Lincomix® Provides Flexible Dosing for M. hyo
Now Lincomix® can be administered at 100 to 200 grams per ton of feed for 21 days to reduce the severity of respiratory disease associated with M. hyo.
Susceptibility to Mycoplasma hyorhinis depending on age
Enric Marco discusses a trial that concludes that the later the infection by M. hyorhinis occurs, the less serious it is. This information can be very useful to devise new control strategies in the era of antibiotic reduction.
Mycoplasma hyopneumoniae vaccination at or shortly before weaning
This study assessed the efficacy of two different Mycoplasma hyopneumoniae vaccination programmes in relation to the time of weaning.
Survey on Mycoplasma hyopneumoniae gilt acclimation practices in Europe
An effective gilt acclimation program should ideally reduce M. hyopneumoniae shedding at first farrowing. The aim of this study was to identify current acclimation strategies for M. hyopneumoniae in Europe.
Two clinical isolates of Mycoplasma hyosynoviae showed differing pattern of lameness
These findings demonstrate that diagnosis of M. hyosynoviae-associated arthritis can be influenced by the clinical isolate, and provides a study platform to investigate the colonization and virulence potential of field isolates.
Assessment of different samples to detect main swine respiratory pathogens
The data present bronchial scraping as an equally effective or even better alternative to bronchoalveolar lavage fluid for detecting main porcine respiratory disease complex agents.
Clinical case: Abattoir lesion prevalence in light and heavy weaned pigs
The prevalence of Mycoplasmal pneumonia and pericarditis lesions was significantly higher in pigs weaned at lower weights compared to their heavier cohorts, despite the provision of a superior production system for the lower weight group.
Immunisation of fattening pigs against influenza: a case study
The reasons behind the vaccination against influenza virus on a group of fattenig units with recurrent respiratory clinical pictures that belong to an integrated production system are discussed. Impact on production parameters and economic results are also shown.
Health protocols for replacements: respiratory and systemic diseases (2/3)
We are talking about PRRSV, M. hyo, PCV2, App and swine influenza virus.
Replacements adaptation in Mycoplasma hyopneumoniae control
Gilts are the population most likely to excrete M. hyo during lactation because they will probably have become infected within 200 days prior to their first farrowing.
Cost of Mycoplasma Hyopneumoniae in growing pigs
Cost Of Mycoplasma Hyopneumoniae In Growing Pigs - Dr. Mark Schwartz, from the 2015 Allen D. Leman Swine Conference, September 19-22, 2015, St. Paul, Minnesota, USA.
Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs
In conclusion, combined vaccination against both Mhp and PRRSV efficiently pooled the efficacy of each single PRRSV and Mhp vaccination and could be an interesting tool to control PRDC in European swine production.
Mycoplasma hyopneumoniae infections in peri-weaned and post-weaned pigs in Belgium and The Netherlands: Prevalence and associations with climatic conditions
Under Belgian and Dutch field conditions, piglets may be infected with M. hyo very early in life, with prevalence increasing further during the post-weaning period.
Ceva enters European swine vaccine market with new, targeted vaccine to improve control of enzootic pneumonia
Experts meet in Barcelona to discuss new strategies to prevent the disease.
In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae
The macrolide tylvalosin and the pleuromutilin valnemulin exhibited the highest in vitro antimicrobial activities against M. hyopneumoniae field isolates in comparison with the other tested antibiotics.